SCHEMBL30133219

SCHEMBL30133219

Oc1cc(O)cc(-c2cn[nH]c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT2 P31751 2/20 0.50
AKT1 P31749 1/20 0.50
ERN1 O75460 1/20 0.46
NT5E P21589 1/20 0.43
ABL1 P00519 2/20 0.41
ABCB1 P08183 1/20 0.41
BCR P11274 1/20 0.41
PIM1 P11309 2/20 0.39
PIM3 Q86V86 2/20 0.39
PIM2 Q9P1W9 2/20 0.39
ROCK2 O75116 2/20 0.39
CHEK1 O14757 1/20 0.38
CHEK2 O96017 1/20 0.38
MAPK1 P28482 2/20 0.38
TNIK Q9UKE5 1/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29431769 0.86 CA12 (0.43) AKT2AKT1ERN1NT5EROCK2
SCHEMBL15849790 0.83 AKT2 (0.61) AKT2AKT1ERN1ABL1PIM1
SCHEMBL29533228 0.83 AKT2 (0.61) AKT2AKT1ERN1ABL1PIM1
SCHEMBL20040983 0.82 NPBWR1 (0.44) AKT2AKT1ERN1NT5EROCK2
SCHEMBL23292140 0.81 FDPS (0.47) AKT2AKT1ERN1NT5EABL1
SCHEMBL29464728 0.81 FDPS (0.47) AKT2AKT1ERN1NT5EABL1
SCHEMBL3740850 0.80 AKT2 (0.70) AKT2AKT1ABL1PIM1PIM3
Hydrochloric Acid SCHEMBL32685369 0.79 FDPS (0.46) AKT2AKT1ERN1NT5EPIM1
SCHEMBL17980346 0.79 NT5E (0.59) AKT2AKT1NT5ECHEK1RPS6KA3
Hydrochloric Acid SCHEMBL23291955 0.79 FDPS (0.46) AKT2AKT1ERN1NT5EPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3386511-B2 METHODS FOR TREATING HUNTINGTON'S DISEASE PTC THERAPEUTICS INC (US) 2024-03-20 EP claimed
CN-115605596-A Compositions and methods for inducible alternative splicing modulation of gene expression 费城儿童医院(US) 2023-01-13 CN disclosed